Patent details

EP3116475 Title: DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS

Basic Information

Publication number:
EP3116475
PCT Application Number:
IL2015050258
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157317272
PCT Publication Number:
WO2015136538
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS
French Title of Invention:
COMPOSITIONS D'INHIBITEURS DE DOPA-DÉCARBOXYLASE
German Title of Invention:
DOPA-DECARBOXYLASEHEMMERZUSAMMENSETZUNGEN
SPC Number:

Dates

Filing date:
12/03/2015
Grant date:
04/11/2020
EP Publication Date:
18/01/2017
PCT Publication Date:
17/09/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/11/2020
EP B1 Publication Date:
04/11/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/03/2021
Expiration date:
12/03/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/10/2020
 
 

Name:
Neuroderm Ltd
Address:
Weizmann Science Park 3 Golda Meir Street, 7403648 Ness Ziona, Israel (IL)

Inventor

Name:
YACOBY-ZEEVI, Oron
Address:
Israel (IL)

Priority

1

Priority Number:
201461952477 P
Priority Date:
13/03/2014
Priority Country:
United States (US)

2

Priority Number:
201461990967 P
Priority Date:
09/05/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 31/133; A61K 31/198; A61K 47/20; A61K 47/22; A61P 25/16; A61K 47/18;

Publication

European Patent Bulletin

Issue number:
202045
Publication date:
04/11/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages